iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.74
0.06 (9.14%)
At close: Aug 15, 2025, 3:59 PM
0.74
-0.01%
After-hours: Aug 15, 2025, 04:11 PM EDT

iBio Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
225K n/a 1.88M 2.37M
Cost of Revenue
1.25M 1.11M 216K 1.46M
Gross Profit
225K -1.11M 2.17M 909K
Operating Income
-16.63M -29.31M -29.7M -31.11M
Interest Income
363K 130K 177K 140K
Pretax Income
-15.44M -29.31M -29.51M -23.21M
Net Income
-24.91M -29.31M -51.01M -23.21M
Selling & General & Admin
11.67M 18.45M 21.75M 22.03M
Research & Development
5.18M 10.33M 9.83M 9.99M
Other Expenses
n/a 565K 13K 12K
Operating Expenses
16.86M 29.34M 31.36M 32.02M
Interest Expense
172K n/a n/a 2.45M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
16.86M 29.34M 52.07M 33.48M
Income Tax Expense
n/a n/a 701K 46K
Shares Outstanding (Basic)
3.83M 1.23M 872.1K 391.24K
Shares Outstanding (Diluted)
3.83M 1.23M 872.1K 391.24K
EPS (Basic)
-6.5 -23.94 -58.49 -60
EPS (Diluted)
-6.5 -23.94 -58.49 -60
EBITDA
-14.02M -28.12M -25.72M -18.34M
EBIT
-15.27M -29.23M -29.51M -20.76M
Depreciation & Amortization
1.25M 1.11M 3.79M 2.41M